| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Division of Endocrinology and Metabolism, Department of Medicine, Cornell University Medical College and The New York Hospital New York, New York 10021
Address requests for reprints to: Marvin C. Gershengorn, M.D., Cornell University Medical College, 1300 York Avenue, New York, NY 10021.
Abstract
TRH evoked a complex electrical membrane response in Xenopus laevis oocytes injected with either total cytosolic or poly(A)+-enriched RNA from GH3 pituitary cells but not in uninjected oocytes. A typical response consisted of a transient, rapid depolarizing current followed by a prolonged depolarizing current with superimposed current fluctuations. The reversal potentials of the rapid and the slow components of the response were –23.0 and –22.6 mV, respectively, and were markedly affected by Cl– concentration indicating that the TRH response was mainly an increase in Cl– conductance. The response to TRH was dose dependent and was inhibited by the TRH antagonist, chlordiazepoxide. TRH caused rapid hydrolysis of labeled phosphatidylinositol 4,5-bisphosphate and a marked, prolonged increase in 45Ca2+ efflux from injected oocytes. The depolarizing response to TRH was not diminished in oocytes incubated in a Ca2+-free medium, but was inhibited by microinjection of EGTA. These data suggest that TRH evokes an electrophysiological response in oocytes injected with RNA from GH3 cells via activation of the same biochemical pathway that mediates its actions in GH3 cells. This pathway involves hydrolysis of phosphatidylinositol 4,5-bisphosphate, forming inositol trisphosphate that causes mobilization of cellular Ca2+. We suggest that oocytes injected with GH3 cell RNA, because of their large size and easy access to their intracellular milieu, will be a useful intact cell model in which to define the molecular details of signal transduction by TRH.
FOOTNOTES
This research project was supported by Grants GA-PS-8524 from the Rockefeller Foundation, 5-RO1-DK 33468-05 and BRSG S07 RR05396 from NIH (to M.C.G.), and by United States-Israel Binational Foundation grant (to Y.O. and M.C.G.).
* Permanent address: Department of Physiology and Pharmacology, Sackler Faculty of Medicine, Tel Aviv University, Ramat Aviv, Israel.
Received for publication August 27, 1987. Accepted for publication October 7, 1987.
This article has been cited by other articles:
![]() |
D. Du, B. M. Raaka, H. Grimberg, M. Lupu-Meiri, Y. Oron, and M. C. Gershengorn Carboxyl Tail Cysteine Mutants of the Thyrotropin-Releasing Hormone Receptor Type 1 Exhibit Constitutive Signaling: Role of Palmitoylation Mol. Pharmacol., July 1, 2005; 68(1): 204 - 209. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Matus-Leibovitch, D. R. Nussenzveig, M. C. Gershengorn, and Y. Oron Truncation of the Thyrotropin-releasing Hormone Receptor Carboxyl Tail Causes Constitutive Activity and Leads to Impaired Responsiveness in Xenopus Oocytes and AtT20 Cells J. Biol. Chem., January 20, 1995; 270(3): 1041 - 1047. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Lupu-Meiri, R. B. Silver, A. H. Simons, M. C. Gershengorn, and Y. Oron Constitutive Signaling by Kaposi's Sarcoma-associated Herpesvirus G-protein-coupled Receptor Desensitizes Calcium Mobilization by Other Receptors J. Biol. Chem., March 2, 2001; 276(10): 7122 - 7128. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |